Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, coagulopathies and disorders of the central nervous system. Its most clinically advanced product candidates are derived from the proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. The company has four ongoing clinical development programs in addition to a diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. The company retains all manufacturing, marketing and distribution rights for its programs.

Acquired Companies: Nura Inc.